Related Experiment Video
Updated: Jul 4, 2026
06:55
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Imputation methods for missing outcome data in meta-analysis of clinical trials
Julian P T Higgins1, Ian R White, Angela M Wood
1MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge, UK. julian.higgins@mrc-bsu.cam.ac.uk
Clinical Trials (London, England)
|June 19, 2008
Summary
Missing data in clinical trials can cause bias. New methods using informative missingness odds ratios (IMORs) help address this uncertainty in meta-analyses, showing robust conclusions for treatments like haloperidol.
Area of Science:
- Biostatistics
- Clinical Trial Methodology
- Evidence Synthesis
Background:
- Missing outcome data in randomized trials introduces uncertainty and potential bias.
- Intention-to-treat analyses require accounting for all randomized participants, including those with missing observations.
Purpose of the Study:
- To review existing and develop novel imputation methods for handling missing outcome data in meta-analyses of binary outcomes.
- To enhance the reliability of meta-analysis findings when faced with incomplete data.
Main Methods:
- Reviewed common imputation strategies like simple imputation.
- Developed a general approach using informative missingness odds ratios (IMORs).
- Explored various study weighting choices and illustrated methods with a meta-analysis of haloperidol trials for schizophrenia.
Main Results:
- IMORs quantify the relationship between risks in missing versus observed participants, allowing differences across groups and trials.
- Applying IMORs and other methods to haloperidol trials demonstrated that conclusions remained robust despite varying assumptions about missing data.
Conclusions:
- Proposed methods utilize summary data (observed outcomes, missing counts) per trial arm.
- Suggested using reasons for missingness to inform IMOR selection and conducting sensitivity analyses by varying IMORs.
Related Concept Videos
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:09Truncation in Survival Analysis
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.
01:09Censoring Survival Data
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...